Evidence map›Paper›PMID 41835907›Full record

ArticleActa medica Philippina2026

Zsarie P Buenavidez, Althea Kathleen P Brum, Krizia Marie T Manzo, Zenia Luisa M Mora, Perlita M Crucis, April Mergelle R Lapuz, Kevin Jace A Miranda, Rogie Royce Z Carandang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta medica Philippina, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zsarie P BuenavidezAdamson University, Manila, Philippines.
Althea Kathleen P BrumAdamson University, Manila, Philippines.
Krizia Marie T ManzoAdamson University, Manila, Philippines.
Zenia Luisa M MoraAdamson University, Manila, Philippines.
Perlita M CrucisAdamson University, Manila, Philippines.
April Mergelle R LapuzAdamson University, Manila, Philippines.
Kevin Jace A MirandaAdamson University, Manila, Philippines.
Rogie Royce Z CarandangAdamson University, Manila, Philippines.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: The Methods: Generic metformin HCl film-coated tablets were subjected to quality control tests, including weight variation, thickness and diameter, hardness, friability, and disintegration tests, in accordance with USP guidelines. To assess Results: All tested generic metformin HCl film-coated tablets complied with USP specifications for quality control tests, except for the hardness test, where three brands failed to meet the required standards. While for dissolution testing, five out of six generic brands demonstrated acceptable dissolution profiles and were bioequivalent to the innovator drug Glucophage. However, one brand (Brand A) failed to meet the bioequivalence criteria, exhibiting a dissolution profile outside the acceptable limits. Conclusion: This study demonstrates that most generic metformin HCl film-coated tablets available in the Philippine market meet the United States Pharmacopeia (USP) quality control requirements and exhibit

Indexed as

disintegration testsdissolutionin-vitro bioequivalencemetformin hydrochloridethickness and diameterUnited States Pharmacopeia (USP)weight variation

Identifiers

PMID41835907
PMCPMC12982900

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.